Muchtar, Eli http://orcid.org/0000-0003-2210-2174
Dispenzieri, Angela
Leung, Nelson http://orcid.org/0000-0002-5651-1411
Lacy, Martha Q.
Buadi, Francis K.
Dingli, David
Hayman, Suzanne R.
Kapoor, Prashant
Hwa, Yi Lisa
Fonder, Amie
Hobbs, Miriam
Gonsalves, Wilson
Kourelis, Taxiarchis V.
Warsame, Rahma
Russell, Stephen J.
Lust, John A.
Lin, Yi
Go, Ronald S. http://orcid.org/0000-0002-8284-3495
Zeldenrust, Steven R.
Kyle, Robert A.
Rajkumar, S. Vincent
Kumar, Shaji K. http://orcid.org/0000-0001-5392-9284
Gertz, Morie A.
Article History
Received: 7 June 2018
Revised: 9 August 2018
Accepted: 14 August 2018
First Online: 26 September 2018
Compliance with ethical standards
:
: AD: Research funding (Celgene, Millennium, Pfizer, and Janssen), Travel grant (Pfizer); MQL: Research funding (Celgene); DD: Research funding (Karyopharm Therapeutics, Amgen, and Millenium Pharmaceuticals); PK: Research funding (Takeda, Celgene, and Amgen); SK: Consultancy (Celgene, Millennium, Onyx, Janssen, and BMS); and research funding (Celgene, Millennium, Novartis, Onyx AbbVie, Janssen, and BMS). MAG: Consultancy (Milleniu) and honoraria (Celgene, Millenium, Onyx, Novartis, Smith Kline, Prothena, Ionis). The remaining authors declare that they have no conflict of interest.